Thrombospondin (TSP)-1 has been reported to modulate T cell behavior both positively and negatively. We found that these opposing responses arise from interactions of TSP1 with two different T cell receptors. The integrin α4β1 recognizes an LDVP sequence in the NH2-terminal domain of TSP1 and was required for stimulation of T cell adhesion, chemotaxis, and matrix metalloproteinase gene expression by TSP1. Recognition of TSP1 by T cells depended on the activation state of α4β1 integrin, and TSP1 inhibited interaction of activated α4β1 integrin on T cells with its counter receptor vascular cell adhesion molecule-1. The α4β1 integrin recognition site is conserved in TSP2. A recombinant piece of TSP2 containing this sequence replicated the α4β1 integrin–dependent activities of TSP1. The β1 integrin recognition sites in TSP1, however, were neither necessary nor sufficient for inhibition of T cell proliferation and T cell antigen receptor signaling by TSP1. A second TSP1 receptor, CD47, was not required for some stimulatory responses to TSP1 but played a significant role in its T cell antigen receptor antagonist and antiproliferative activities. Modulating the relative expression or function of these two TSP receptors could therefore alter the direction or magnitude of T cell responses to TSPs.
Skip Nav Destination
Article navigation
29 April 2002
Article|
April 29 2002
Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior
Zhuqing Li,
Zhuqing Li
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Maria J. Calzada,
Maria J. Calzada
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
John M. Sipes,
John M. Sipes
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Jo Anne Cashel,
Jo Anne Cashel
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Henry C. Krutzsch,
Henry C. Krutzsch
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Douglas S. Annis,
Douglas S. Annis
2Department of Medicine, University of Wisconsin-Madison, Madison, WI 53706
Search for other works by this author on:
Deane F. Mosher,
Deane F. Mosher
2Department of Medicine, University of Wisconsin-Madison, Madison, WI 53706
Search for other works by this author on:
David D. Roberts
David D. Roberts
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Zhuqing Li
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Maria J. Calzada
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
John M. Sipes
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Jo Anne Cashel
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Henry C. Krutzsch
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Douglas S. Annis
2Department of Medicine, University of Wisconsin-Madison, Madison, WI 53706
Deane F. Mosher
2Department of Medicine, University of Wisconsin-Madison, Madison, WI 53706
David D. Roberts
1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Address correspondence to David D. Roberts, National Institutes of Health, Building 10, Room 2A33, 10 Center Dr. MSC 1500, Bethesda, MD 20892-1500. Tel.: (301) 496-6264. Fax: (301) 402-0043. E-mail: [email protected]
*
Abbreviations used in this paper: FN, fibronectin; GST, glutathione-S-transferase; HSPG, heparan sulfate proteoglycan; MMP, matrix metalloproteinase; NoC1, trimeric human thrombospondin-1 residues 1–356; NoC2, thrombospondin-2 residues 1-359; RT-PCR, reverse transcriptase-PCR; TCR, T cell antigen receptor; TSP, thrombospondin; VCAM-1, vascular cell adhesion molecule-1.
Received:
September 26 2001
Revision Received:
March 20 2002
Accepted:
March 20 2002
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2002
J Cell Biol (2002) 157 (3): 509–519.
Article history
Received:
September 26 2001
Revision Received:
March 20 2002
Accepted:
March 20 2002
Citation
Zhuqing Li, Maria J. Calzada, John M. Sipes, Jo Anne Cashel, Henry C. Krutzsch, Douglas S. Annis, Deane F. Mosher, David D. Roberts; Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior . J Cell Biol 29 April 2002; 157 (3): 509–519. doi: https://doi.org/10.1083/jcb.200109098
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement